Percutaneous pulmonary valve implantation safely reduced the average peak-to-peak right ventricular outflow tract gradient from 50 mmHg to 8 mmHg and improved average functional class from III/IV to I/IV.
Observational (n=10)
No
Does percutaneous pulmonary valve implantation improve functional class and reduce RVOT gradients in patients with congenital heart disease and RVOT dysfunction?
Percutaneous pulmonary valve implantation is a viable, less invasive alternative to surgery that effectively reduces RVOT gradients and improves functional class in patients with congenital heart disease.
Lozano-Espinosa et al. (Fri,) conducted a observational in Congenital heart disease requiring right ventricular outflow tract intervention (n=10). Percutaneous pulmonary valve implantation (Melody or Myval valve) was evaluated on Peak-to-peak RVOT gradient and NYHA functional class. Percutaneous pulmonary valve implantation safely reduced the average peak-to-peak right ventricular outflow tract gradient from 50 mmHg to 8 mmHg and improved average functional class from III/IV to I/IV.